Navigation Links
Pharmasset Reports Fiscal Second Quarter 2009 Financial Results
Date:5/11/2009

he Phase 2b with Roche in second half of 2009;
  • Report phase 1 antiviral data with PSI-7851 in second half of 2009;
  • Report further data from INFORM-1 trial in fourth quarter of 2009.

  • About Pharmasset

    Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis C virus (HCV) and, secondarily, on the development of Racivir(R) for the treatment of human immunodeficiency virus (HIV). Our research and development efforts focus on nucleos(t)ide analogs, a class of compounds which act to inhibit the enzymes required for viral replication. We currently have three clinical-stage product candidates: R7128, a nucleoside analog for chronic HCV infections, has initiated a Phase 2b clinical trial in combination with Pegasys plus Copegus through a strategic collaboration with Roche; PSI-7851, an unpartnered, next generation HCV nucleotide analog, which recently began Phase 1 clinical studies and Racivir, for the treatment of HIV that has completed a Phase 2 clinical trial.

    Pegasys(R) and Copegus(R) are registered trademarks of Roche.

        Contact
        Richard E. T. Smith, Ph.D.
        VP, Investor Relations and Corporate Communications
        richard.smith@pharmasset.com
        Office: +1 (609) 613-4181
    

    Forward-Looking Statements

    Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation, the risk that adverse events could cause the cessation or delay of any
    '/>"/>

    SOURCE Pharmasset, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
    2. Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th
    3. Pharmasset Accesses up to $30 Million of Working Capital
    4. Pharmasset to Present at Three Investor Conferences in November 2007
    5. Pharmasset Appoints Michael Rogers as Chief Development Officer
    6. Pharmasset Reports Fiscal Year End 2007 Financial Results
    7. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
    8. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
    9. Pharmasset to Present at Cowen & Companys Health Care Conference on Tuesday, March 18th
    10. Pharmasset Appoints Herbert J. Conrad as a Director
    11. Pharmasset Receives $10 Million of Working Capital
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... 2014 Look inside the new Preferred ... the lab, from fluid handling to instruments to supplies. ... when you order. , Preferred Solutions features a ... the L/S® model for precise flow control and dispensing ...
    (Date:1/15/2014)... A study has been launched to test whether technology ... help to tackle the problem of obesity.  This unique healthcare ... based in Stowmarket) and academics at University Campus Suffolk is ... which is inspired by equipment used to collect data about ...
    (Date:1/15/2014)... 2014 2013 was a banner year ... Technologies®. They saw continued independent research led by the ... awarded a $1 million grant from the Susanne Marcus ... Behavior” a peer reviewed journal, Amy Grant highlighted Brainwave ...
    (Date:1/14/2014)... 2014 Carahsoft and CDS Federal Services ... 2014 at 2pm EST (11am PST), “Natural Language Processing: ... on how technology can turn raw, heterogeneous data into ... agencies. The online webinar will last approximately one hour. ...
    Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2
    ... a down economy at all. PHC Consulting is focused on top ... and research, physician call points, medical devices, pharmaceutical, etc). So far, ... growth to a strong web presence. , ... Celina, ...
    ... genetics,(Nasdaq: DCGN ) today announced that it will ... to be held in New York., The presentations ... Eastern Time/5pm GMT/6pm British Summer time, at the Gansevoort ... approximately three and a half,hours. The webcast can be ...
    ... Technology Awards Foundation Pays Tribute to Individuals ... ... 24 ARUP Laboratories, a national,clinical and anatomic pathology reference ... today that its,Case Study for "ARUP Consult(R), The Physician,s Guide ...
    Cached Biology Technology:Website and Blog Increase Placement for Medical Sales Recruiter - Providing Sales Winners Calling on the Hospital, Lab and Physician Call Point 2deCODE genetics to Webcast Presentations at Annual R&D Event 2deCODE genetics to Webcast Presentations at Annual R&D Event 3ARUP Laboratories' ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate 2ARUP Laboratories' ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate 3
    (Date:4/24/2014)... generation of military veterans returning home from Iraq and ... concern in American medical institutions and the culture at-large. ... personnel deployed to Iraq and Afghanistan suffer from PTSD. ... of Medicine is shedding light on how PTSD is ... , The rise in PTSD has implications beyond the ...
    (Date:4/24/2014)... droplet of clear liquid can bend light, acting as ... have developed a new process to create inexpensive high ... apiece. , Because they,re so inexpensive, the lenses ... tools to detect diseases in the field, scientific research ... education in classrooms. , "What I,m really excited ...
    (Date:4/23/2014)... Africa,s Congo rainforest, the second-largest tropical rainforest in the ... the past decade. , The study, led by Liming ... York, shows between 2000 and 2012 the decline affected ... research, published Wednesday in Nature , is one ... effects of long-term drought on the Congo rainforest using ...
    Breaking Biology News(10 mins):New study links inflammation in those with PTSD to changes in microRNA 2New study links inflammation in those with PTSD to changes in microRNA 3Bake your own droplet lens 2Bake your own droplet lens 3NASA satellites show drought may take toll on Congo rainforest 2NASA satellites show drought may take toll on Congo rainforest 3
    ... which sexual harassment from males can damage relationships between females ... Led by the Centre for Research in Animal Behaviour at ... the Royal Society B , the research uncovers the effect ... form social bonds with each other. The study focused ...
    ... that the presence of the rare element osmium is ... the consumption of refined platinum, the primary ingredient in ... reduce smog. A volatile form of osmium is generated ... of cars, and it gets dispersed globally through the ...
    ... offered by the green economy in the current economic ... leading experts in the fields of economics and environmental ... Centre, Professor Paul Ekins of Kings College, London and ... Economic Performance. ,Is the recession an opportunity ...
    Cached Biology News:Sexual harassment from males prevents female bonding, says study 2Increasing levels of rare element found worldwide 2Saving the economy and saving the planet 2
    Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
    Human peripheral blood CD14+ monocytes, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
    Human endothelial progenitor cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
    Yeast tRNA 50 l...
    Biology Products: